Cognitive deterioration after consumption of cannabis;Deterioro cognitive tras consume de cannabis

Revista de Neurologia

Volumn 33, Issue 5, 2001, Pages 482-486

  Núñez Domínguez, Luis Alfonso ^a  

^a Hospital San Francisco Javier   (Spain)

Author keywords

Cannabis; Long term use; Permanent cognitive impairment

Indexed keywords

ACUTE DISEASE; CANNABIS ADDICTION; COGNITIVE DEFECT; COMPUTER INTERFACE; CONFERENCE PAPER; HOSPITALIZATION; HUMAN; NEUROPSYCHOLOGICAL TEST; TIME;

ACUTE DISEASE; COGNITION DISORDERS; ENGLISH ABSTRACT; HUMAN; MARIJUANA ABUSE; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; USER-COMPUTER INTERFACE;

EID: 0346488835     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3305.2000211     Document Type: Article

References (46)

1. Thomas H. Psychiatric symptoms in cannabis users. Br J Psychol 1993; 163: 141-9.
2. Núñez Domínguez LA. Cannabis y psicosis. Relaciones etiopatogénicas. Adicciones 1997; 9: 129-43.
3. Emrich HM, Leweke FM, Schneider U. Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav 1997; 56: 803-7.
4. Andreasson S, Allebeck P, Engström A, Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987; 2: 1483-6.
5. Miller LL. Marijuana: acute effects on human memory. In Augurel S, Dewey WL, Willette RE, eds. The cannanbinoid: chemical, pharmacologic and therapeutic aspects. Orlando: Academic Press; 1984. p. 21-46.
6. Musty R. Individual differences as predictors of marihuana phenomenology. In Chesher G, Conroe P, Musty R, eds. Marihuana: an international research report. National Campaign Against Drug Abuse. Monograph Series N.o 7. Camberra: Australian Government Printing Service; 1998. p. 201-6.
7. Petwee RG. In vivo interactions between psychotropic cannabinoids and others drugs involving central and peripheral neurochemical mechanisms. In Murphy L, Bartke A, eds. Marijuana/cannabinoids: neurobiology and neurophysiology. Boca Raton: CRC Press; 1992. p. 165-218.
8. Terranova JP, Storme JJ, Lafon N, Perio A, Rinaldi-Carmona M, et al. Improvement of memory in rodents by the selective CBI cannabinoid receptor antagonist SR 141716. Psychopharmacology 1996; 126: 165-72.
9. Fried PA, Charlebois AT. Cannabis administered during pregnancy: first and second generation effects in rats. Physiologist 1979; 7: 307-10.
10. Rosenkrantz H. Cannabis, marihuana and cannabinoid toxicological manifestations in man and animals. In Fehr KO, Kalant H, eds. Cannabis and health hazards. Proceedings of an ARF/WHO Scientific Meeting on Adverse Health and Behavioral Consequences of Cannabis Use, 75. Toronto: Addiction Research Foundation; 1983. p. 91-175.
11. Nakamura EM, Da Silva EA, Concilio GV, Wilkinson DA, Masur W. Reversible effects of acute and long-term administration of delta 9-tetrahydrocannabinol (THC) on memory in rats. Drug Alcohol Depend 1991; 28: 167-75.
12. Fried P. Behavioral outcomes in preschool and school-age children exposed prenatally to marijuana: a review and speculative interpretation. In Wetherington CL, Smeriglio VL, Finnegan LP, eds. Behavioral studies of drug exposed offspring: methodological issues in human and animal research. Washington: United States Government Printing Office; 1996. p. 242-60.
13. Fernández Ruiz JJ, Romero J, Gracía L, García Palomer E, Ramos JJ. Dopaminergic neurons as neurochemical substrates of neurobehavioral effects of marihuana: developmental and adult studies. In Beninger RJ, Palomo T, Archer T, eds. Dopamine disease states. Madrid: CYM; 1996. p. 359-89.
14. Kolansky H, Moore RT. Toxic effects of chronic marihuana use. JAMA 1972; 222: 35-41.
15. Tennant FS, Groesbeck CJ. Psychiatric effects of hashish. Arch Gen Psychiatry 1972; 27: 133-6.
16. TunvingK, Lundqvist T, Eriksson D. A way out of the fog: an outpatient program for cannabis users. In Chesher G, Conroe P, Musty R, eds. Marihuana: an international research report. National Campaign Against Drug Abuse. Monograph Series N.o 7. Camberra: Australian Government Printing Service; 1998. p. 207-12.
17. Lundqvist T. Cognitive dysfunctions in chronic cannabis users observed during treatment: an integrative approach. University of Lund and Stockholm: Aalmqvist & Wiksell International; 1995.
18. Soueif MI. Chronic cannabis users: Further analysis of objective test results. Bull Narc 1975; 27: 1-26.
19. Bowman M, Phil RO. Cannabis: psychological effects of chronic heavy use. A controlled study of intellectual functioning in chronic users of high potency cannabis. Psychopharmacology 1973; 29: 159-70.
20. Rubin V, Comitas L. Ganja in Jamaica: a medical anthropological study of chronic marijuana use. The Hague: Mouton Publishers: 1975.
21. Stefanis C, Dornbush R, Fink M. Hashih studies of long-term use. New York: Raven Press; 1977.
22. Page JB, Fletcher J, True WR. Psychosocial perspectives on chronic cannabis use: the Costa Rican follow-up. J Psychoactive Drugs 1988; 20: 57-65.
23. Agarwall AK, Sethi BB, Gupta SC. Psychical and cognitive effects of chronic bhang (cannabis) intake. Indian J Psychol 1975; 17: 1-7.
24. Wig NN, Varma VK. Patterns of long-term heavy cannabis use in North India and its effects on cognitive functions: a preliminary report. Drug Alcohol Depend 1977; 2: 211-9.
25. Mendhiratta SS, Wig NN, Verma SK. Some psychological conlates of long-term heavy cannabis users. Br J Psychol 1978; 132: 482-6.
26. Ray R, Prabhu GG, Mohan D, Nath LM, Nekki JS. The association between chronic cannabis use and cognitive functions. Drug Alcohol Depend 1978; 3: 365-8.
27. Varma VJ, Malhotra AK, Dang R, Nehra R. Cannabis and cognitive functions: a prospective study. Drug Alcohol Depend 1988, 21: 147-52.
28. Schwartz RH, Gruenewald PJ, Klitzner M, Fedio P. Short-term memory impairment in cannabis-dependent adolescents. Am J Dis Child 1989; 143: 1214-9.
29. Millsaps CL, Azrin RL, Mittenbarg W. Neuropsychological effects of chronic cannabis use on the memory and intelligence of adolescents. J Child Adolesc Subst Abuse 1994; 3: 47-55.
30. Campbell AMG, Evans M, Thompson JLG, Williams MJ. Cerebral atrophy in young cannabis smokers. Lancet 1971; 2: 1219-24.
31. Co BT, Goodwin DW, Gado M, Mikhael M, Hill SY. Absence of cerebral atrophy in chronic cannabis users: evaluation by computerized transaxial tomography. JAMA 1977; 237: 1229-30.
32. Kuehnle J, Mendelson JH, Davis KR. Computed tomographic examination of heavy marijuana users. JAMA 1977: 237: 1231-2.
33. Struve F, Straumanis J, Patrick G, Norris G, Leavitt J, Webb P. Topographic quantitative EEG findings in subjects with 15+ years of cumulative daily THC exposure. In Harris L, eds. Problems of drug dependence. National Institute on Drug Abuse Research, Monograph N.o 119. Washington: United States Government Printing Office; 1991. p. 451.
34. Struve F, Straumanis J, Patrick G, Norris G, Nixon F. Fitzgerald M, et al. Altered quantitative EEG topography as sequeale of chronic THC exposure: A replication using normal Ss. In Harris L, eds. Problems of drug dependence. National Institute on Drug Abuse Research, Monograph N.o 132. Washington: United States Government Printing Office; 1992. p. 178.
35. Sturve F, Strumanis JJ, Patrick G. Persistent topographic quantitative EEG sequelae of chronic marihuana use: a replication study and initial discrimination function analysis. Clin Electroencephalogr 1994; 25: 63-75.
36. Struve F, Patrick G, Leavitt J. Development of a 'composite' measure of alpha hyperfrontality for use in THC research. In Harris L, eds. Problems in drug dependence. National Institute on Drug Abuse Research, Monograph N.o 153. Washington: United States Government Printing Office; 1994. p 505.
37. Struve F, Manno BR, Straumanis JJ. Theta hyperfrontality: an aditional quantitative EEG sequela of acute and chronic marihuana (THC) exposure. Symposium on the Cannabinoids. Burlington: International Cannabinoid Research Society; 1988. p. 84.
38. Tunving K, Thulin O, Risberg J, Warkentin S. Regional cerebral blood flow in long-term cannabis heavy cannabis use. Psychol Res 1986; 17: 15-21.
39. Mathew RJ, Wilson WH. The effects of marijuana on cerebral blood and metabolism. In Murphy L, Bartke A, eds. Marijuana/cannabinoids: neurobiology and neurophysiology, Boca Ratón: CRC Press; 1992. p. 337-86.
40. Volkow ND, Gillespie H, Mullani N, Tancredi L, Grant C. et al. Use of positron emission tomography to investigate the action of marihuana in the human brain. In Nahas G, Latour C, eds. Physiopathology of illicit drugs: cannabis, cocaine, opiates. Oxford: Pergamon Press; 1991. p. 3-11.
41. Volkow ND, Gillespie H, Mullani N, Tancredi L, Grant C, Vanetine A, et al. Brain glucose-metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatr Res Neuroimaging 1996; 67: 29-38.
42. Rodriguez de Fonseca F, Gorriti M, Fernández Ruiz JJ, Palomo T, Ramos JA. Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment. Pharmacol Biochem Behav 1994; 47: 33-40.
43. Heyser CJ, Hampson RE, Deadwyler SA. Effects of 9-delta-tetrahy-drocannabinol on delayed match-to-sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampus cells. J Pharmacol Exp Ther 1993; 264: 294-307.
44. Solowji N. Do cognitive impairments recover following cessation of cannabis use? Life Sci 1995; 56: 2119-26.
45. Solowji N, Michie, PT, Fox AM. ERP indices of selective attention in ex-cannabis users. Biol Psychol 1995; 23: 17-28.
46. Solowji N. Cannabis and cognitive functioning. International Research Monographs in the Addictions. Cambridge: University Press; 1998. p 170-91.